Influence of fluoride treatment on surface properties, biodegradation and cytocompatibility of Mg-Nd-Zn-Zr alloy

Journal of Materials Science: Materials in Medicine

Volumn 25, Issue 3, 2014, Pages 791-799

  Zhang, Jian ^a   Kong, Ni ^b   Niu, Jialin ^a   Shi, Yongjuan ^a   Li, Haiyan ^b   Zhou, Yue ^b   Yuan, Guangyin ^a,b  

^a Shanghai Jiao Tong University   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; BIOCOMPATIBILITY; BIODEGRADATION; CELL ADHESION; HYDROFLUORIC ACID; MAGNESIUM ALLOYS; SURFACE PROPERTIES; SURFACE ROUGHNESS; ZINC; ZIRCONIUM; ZIRCONIUM ALLOYS;

CARDIOVASCULAR STENTS; DEGRADATION KINETICS; DIRECT CELL ADHESION; FIBRINOGEN ADSORPTION; MG-ND-ZN-ZR ALLOYS; STATIC CONTACT ANGLE; SURFACE CHARACTERISTICS; SURFACE ZETA POTENTIAL;

DEGRADATION;

ALLOY; FIBRINOGEN; FLUORIDE; HUMAN ALBUMIN; HYDROFLUORIC ACID; MAGNESIUM; NEODYMIUM; ZINC; ZIRCONIUM;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CARDIOVASCULAR STENT; CELL ADHESION ASSAY; CELL SPREADING; CELL STRUCTURE; CELL VIABILITY; CONTACT ANGLE; CONTROLLED STUDY; CYTOCOMPATIBILITY; ENERGY; HUMAN; HUMAN CELL; HYDROPHILICITY; IMPLANT; IN VITRO STUDY; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL;

ALLOYS; BIOCOMPATIBLE MATERIALS; BODY FLUIDS; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; FLUORIDES; HUMANS; MAGNESIUM COMPOUNDS; MATERIALS TESTING; SURFACE PROPERTIES;

EID: 84896544314     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-5106-z     Document Type: Article

References (32)

1. Raimund E, Carlo DM, Jozef B, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents a prospective non-randomised multicentre trial. Lancet. 2007;369:1869-75.
2. Haude M, Erbel R, Erne P, Verheye S, Degen H, Böse D, Vermeersch P, Wijnbergen I, Weissman N, Prati F, Waksman R, Koolen J. Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet. 2013;381:836-44.
3. Hornberger H, Virtanen S, Boccaccini AR. Biomedical coatings on magnesium alloys - a review. Acta Biomater. 2012;8:2442-5.
4. Pereda MD, Alonso C, Burgos-Asperilla L, del Valle JA, Ruano OA, Perez P, de Fernández Lorenzo Mele MA. Corrosion inhibition of powder metallurgy Mg by fluoride treatments. Acta Biomater. 2010;6:1772-82.
5. Ma Y, Li N, Li D, Zhang M, Huang X. A two-step surface treatment, combining fluoride pretreatment and anodic electrophoresis deposition of waterborne acrylic resin, for Mg-Li-Al-Ce alloy. Mater Lett. 2013;90:11-3.
6. Yan T, Tan L, Xiong D, Liu X, Zhang B, Yang K. Fluoride treatment and in vitro corrosion behavior of an AZ31B magnesium alloy. Mater Sci Eng C. 2010;30:740-8.
7. Chen Y, Song Y, Zhang S, Li J, Wang H, Zhao C, Zhang X. Effect of fluoride coating on in vitro dynamic degradation of Mg-Zn alloy. Mater Lett. 2011;65:2568-71.
8. Drynda A, Hassel T, Hoehn R, Perz A, Bach F-W, Peuster M. Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications. J Biomed Mater Res A. 2009;9999A:763-75.
9. Drynda A, Seibt J, Hassel T, Bach FW, Peuster M. Biocompatibility of fluoride-coated magnesium-calcium alloys with optimized degradation kinetics in a subcutaneous mouse model. J Biomed Mater Res Part A. 2012;00A:000.
10. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins a review. Tissue Engineering. 2005;11:1-18.
11. Mao L, Shen L, Niu J, Zhang J, Ding W, Wu Y, Fan R, Yuan G. Nanophasic biodegradation enhances the durability and biocompatibility of magnesium alloys for the next-generation vascular stents. Nanoscale. 2013;5:9517-22.
12. Mao L, Yuan G, Niu J, Zong Y, Ding W. In vitro degradation behavior and biocompatibility of Mg-Nd-Zn-Zr alloy by hydrofluoric acid treatment. Mater Sci Eng C. 2012;33:242-50.
13. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27:2907-15.
14. Michiardi A, Aparicio C, Ratner BD, Planell JA, Gil J. The influence of surface energy on competitive protein adsorption on oxidized NiTi surfaces. Biomaterials. 2007;28:586-94.
15. Li H, Daculsi R, Grellier M, Bareillie R, Bourget C, Amedee J. Role of neural-cadherin in early osteoblastic differentiation of human bone marrow stromal cells cocultured with human umbilical vein endothelial cells. Am J Physiol Cell Physiol. 2010;299:422-30.
16. Atrens A, Liu M, Zainal Abidin NI. Corrosion mechanism applicable to biodegradable magnesium implants. Mater Sci Eng B. 2011;176:1609-36.
17. Whitford GM. Intake and metabolism of fluoride. Adv Dent Res. 1994;8:5-14.
18. Xin Y, Hu T, Chu PK. In vitro studies of biomedical magnesium alloys in a simulated physiological environment: a review. Acta Biomater. 2011;7:1452-9.
19. Witte F, Fischer J, Nellesen J, Vogt C, Vogt J, Donath T, Beckmann F. In vivo corrosion and corrosion protection of magnesium alloy LAE442. Acta Biomater. 2010;6:1792-9.
20. Valagao AP. Bovine serum albumin adsorption on titania surfaces and its relation to wettability aspects. J Biomed Mater Res. 1999;46:376-81.
21. Nakanishi K. On the adsorption of proteins on solidsurfaces, a common but very complicated phenomenon. J Biosci Bioeng. 2001;91:233-44.
22. Brash JL. Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials. J Biomater Sci Polym Edn. 2000;11:1135-46.
23. Bennett MR. In-stent stenosis pathology and implications for the development of drug eluting stents. Heart. 2003;89:218-24.
24. Cai K, Frant M, Bossert J, Hildebrand G, Liefeith K, Jandt KD. Surface functionalized titanium thin films: zeta-potential, protein adsorption and cell proliferation. Colloids Surf B. 2006;50:1-8.
25. Newby AC. Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190:300-9.
26. Vormann J. Magnesium nutrition and metabolism. Mol Aspects Med. 2003;24:27-37.
27. Feyerabend F, Fischer J, Holtz J, Witte F, Willumeit R, Drücker H, Vogt C, Hort N. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines. Acta Biomater. 2010;6:1834-42.
28. Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Arch Biochem Biophys. 2007;458:90-102.
29. Zhang H. Subchronic toxicity of rare earth elements and estimated daily intake allowance. Ninth annual V. M. goldschmidt conference. Cambridge, Massachusetts. August 22-27. 1999, Abstract no. 7025.
30. Hirano S. Exposure, metabolism, and toxicity of rare earths and related compounds. Environ Health Perspect. 1996;104(Suppl):85-95.
31. Hallab NJ. Evaluation of metallic and polymeric biomaterial surface energy and surface roughness characteristics for directed cell adhesion. Tissue Eng. 2001;7:55-71.
32. Fischer J, Pröfrock D, Hort N, Willumeit R, Feyerabend F. Improved cytotoxicity testing of magnesium materials. Mater Sci Eng B. 2011;176:830-4.